title: Doppler characterization of left ventricular diastolic function in cardiac amyloidosis.
abstract: Sixty-four patients with primary systemic amyloidosis-53 with two-dimensional echocardiographic features of cardiac involvement (Group I) and 11 without cardiac involvement (Group II)--underwent Doppler echocardiographic assessment of left ventricular diastolic function. Pulsed wave Doppler recordings of left ventricular inflow velocities and pulmonary vein flow velocities with respiratory monitoring in these patients were compared with findings in a normal group. Patients in Group I showed striking abnormalities of left ventricular diastolic filling when classified into subgroups by mean left ventricular wall thickness: early greater than 12 but less than 15 mm; advanced greater than or equal to 15 mm. In early amyloidosis, relaxation was abnormal, with decreased peak early velocity (75 +/- 20 versus 86 +/- 16 cm/s; p less than 0.01), increased late velocity (71 +/- 22 versus 56 +/- 13 cm/s; p less than 0.01), decreased early to late velocity ratio (1.2 +/- 0.6 versus 1.6 +/- 0.5; p less than 0.01) and prolonged isovolumic relaxation time (87 +/- 15 versus 73 +/- 13 ms; p less than 0.01) compared with normal values. In advanced amyloidosis, there was a restrictive filling pattern with a markedly shortened deceleration time (148 +/- 50 versus 199 +/- 32 ms; p less than 0.001), decreased pulmonary vein peak systolic flow velocity (34 +/- 16 versus 54 +/- 12 cm/s; p less than 0.01) and increased diastolic flow velocity (55 +/- 20 versus 44 +/- 12 cm/s; p less than 0.01) compared with normal values. Group and the subgroup with early amyloidosis had similar flow velocity patterns. Thus, this study documents that in cardiac amyloidosis, a spectrum of diastolic filling abnormalities exists; the restrictive filling pattern is seen only in the advanced stages.
authors.affiliation: Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.
authors.forename: A L
authors.initials: AL
authors.lastname: Klein
authors.forename: L K
authors.initials: LK
authors.lastname: Hatle
authors.forename: D J
authors.initials: DJ
authors.lastname: Burstow
authors.forename: J B
authors.initials: JB
authors.lastname: Seward
authors.forename: R A
authors.initials: RA
authors.lastname: Kyle
authors.forename: K R
authors.initials: KR
authors.lastname: Bailey
authors.forename: T F
authors.initials: TF
authors.lastname: Luscher
authors.forename: M A
authors.initials: MA
authors.lastname: Gertz
authors.forename: A J
authors.initials: AJ
authors.lastname: Tajik
mesh_terms: D000686:Amyloidosis / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D001783:Blood Flow Velocity; D003326:Coronary Circulation; D003971:Diastole; D004452:Echocardiography; D005260:Female; D006321:Heart / Q000503:physiopathology*; D006331:Heart Diseases / Q000150:complications / Q000503:physiopathology*; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000150:complications; D009200:Myocardial Contraction; D009206:Myocardium / Q000473:pathology; D011667:Pulmonary Veins / Q000503:physiopathology; D013599:Systole; D014463:Ultrasonography